Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

96.94
+0.26000.27%
Post-market: 96.940.00000.00%19:30 EDT
Volume:9K
Turnover:882.27K
Market Cap:399.39M
PE:54.06
High:96.95
Open:96.84
Low:96.67
Close:96.68
52wk High:98.82
52wk Low:67.69
Shares:4.12M
Float Shares:4.12M
Volume Ratio:0.47
T/O Rate:0.22%
Dividend:1.55
Dividend Rate:1.60%
EPS(TTM):1.79
EPS(LYR):18.65
ROE:24.76%
ROA:0.08%
PB:1.61
PE(LYR):5.20

Loading ...

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 10

Shares of Vertex Pharma up 7.7% Premarket After Rival Genetic Disorder Drug Setback

THOMSON REUTERS
·
Aug 10

Sionna Scraps Genetic Disorder Drug Program After Trial Setback; Shares Tank

Reuters
·
Aug 10

Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:

GlobeNewswire
·
Aug 10

Sino Biopharmaceutical Stock Sheds 0.9% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 10

Amgen Inc : HSBC Raises Target Price to $445 from $425

THOMSON REUTERS
·
Aug 10

Insiders Shake Up General Dynamics, Thermo Fisher, Carvana, Biogen, Charles Schwab

TIPRANKS
·
Aug 08

Amgen SVP, Chief Compliance Officer Nancy Grygiel Sells 2,970 Shares for $1.2 Million

Reuters
·
Aug 08

Canada's DRI Healthcare Q2 Income Rises, Helped by Milestone Events in Royalty Portfolio

Reuters
·
Aug 08

Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock is Tumbling.

Dow Jones
·
Aug 08

Grail announces FDA advisory committee meeting to review Galleri test PMA

TIPRANKS
·
Aug 07

Xenetic Biosciences Q2 Royalty Revenue Rises on Takeda Sublicense

Reuters
·
Aug 07

Sino Biopharmaceutical Stock Climbs 3.3% in Hong Kong, Outperforms Competitors

Dow Jones
·
Aug 07

Biogen completes acquisition of RayThera

TIPRANKS
·
Aug 07

Biogen Completes Acquisition of RayThera

Reuters
·
Aug 07

Biogen Completes Acquisition of Raythera Inc.

THOMSON REUTERS
·
Aug 07

Halozyme Q2 Revenue Jumps 48%, Raises 2026 Outlook

Reuters
·
Aug 07

Vortex Energy Study Confirms Major Salt Structure and New Target at Robinsons River

TIPRANKS
·
Aug 07

Biogen Extends Felzartamab Kidney Rejection Trial, Bolstering Long-Term Pipeline Story

TIPRANKS
·
Aug 07

Salesforce, UnitedHealth Share Losses Contribute to Dow's Nearly 150-Point Drop

Dow Jones
·
Aug 06